US FDA considers new labelling policy for home-use devices
This article was originally published in SRA
The US Food and Drug Administration has launched a new initiative aimed at assuring the safe use of medical devices in patients’ homes1.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.